Cortistatin-17 (human)
Product Specifications
UNSPSC Description
Cortistatin-17 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2].
Target Antigen
Somatostatin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cortistatin-17-human.html
Purity
98.77
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)CC2=CC=CC=C2)=O)CO)=O)CO)=O)C(N[C@H](C(O)=O)CCCCN)=O)NC([C@H]3N(CCC3)C([C@H](CCSC)NC([C@H](CCCNC(N)=N)NC([C@@H](N)CC(O)=O)=O)=O)=O)=O)=O)CCCNC(N)=N)=O)CC(N)=O)=O)CC4=CC=CC=C4)=O)CC5=CC=CC=C5)N[C@H]1CC6=CNC7=CC=CC=C67
Molecular Weight
2151.49
References & Citations
[1]Spier AD, et al. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41. |[2]Campos-Salinas J, et al. Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders. Pharmaceutics. 2022 Dec 13;14(12):2785.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5011/Cortistatin-17-human-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5011/Cortistatin-17-human-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
189450-19-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
